In 2023, the United States led global scientific publications in pulmonary and respiratory medicine, commanding 22.93% of worldwide share, followed by China with 13.83% and Japan at 7.39%. Notably, China and India exhibited notable growth with year-on-year increases of 9.14% and 8.08%, respectively. European countries like Italy and France experienced slight declines. Emerging countries such as Egypt and Malaysia surged significantly with growth rates over 17%. Over the past five years, a diverse CAGR has shaped contributions, reflecting varied research investments across continents.
Looking ahead, expect continued growth in publications from countries like Vietnam and Indonesia, fueled by increasing healthcare investments and research funding. An eye should also be kept on China's accelerated pace, potentially closing gaps with traditional leaders like the US. Emerging markets in Southeast Asia and the Middle East are anticipated to progressively enrich global scientific outputs, driven by economic development and enhanced research infrastructure.
Top countries in Total Number of Scientific Publications in Pulmonary and Respiratory Medicine Share by Country (Units (Publications))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 22.93 | 2023 | +2.52% | +2.29% | View data |
| 2 | 2 China | 13.83 | 2023 | +8.95% | +9.14% | View data |
| 3 | 3 Japan | 7.39 | 2023 | +0.21% | +2.08% | View data |
| 4 | 4 United Kingdom | 5.81 | 2023 | +1.08% | +0.88% | View data |
| 5 | 5 Germany | 5.1 | 2023 | +1% | +0.45% | View data |
| 6 | 6 Italy | 4.66 | 2023 | +2.2% | -1.27% | View data |
| 7 | 7 Spain | 4.55 | 2023 | +3.16% | +3.22% | View data |
| 8 | 8 France | 4.19 | 2023 | -0.059% | -0.86% | View data |
| 9 | 9 Australia | 3.63 | 2023 | +3.82% | +6.94% | View data |
| 10 | 10 Canada | 3.41 | 2023 | +1.74% | +0.18% | View data |
